Sorry!! The article you are trying to read is not available now.
November 15, 2012 at 05:38 AM EST
Merck KGaA expects to publish Stimuvax data in Q1 2013
FRANKFURT, Nov 15 (Reuters) - German drugmaker Merck KGaA expects first late-stage study results on cancer drug Stimuvax to be available in the first quarter of next year, its chief executive said on Thursday.
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here

WHAT'S POPULAR IN THE VILLE